ID

11717

Descripción

The purpose of this study is to test the hypothesis that the inhibition of the renin-angiotensin-aldosterone system (RAAS) with the angiotensin receptor blocker valsartan or the renin antagonist aliskiren will improve ventricular hemodynamics, as reflected by a greater reduction in levels of N-terminal proB-type natriuretic peptide (NT-proBNP) compared to placebo in subjects stabilized following acute coronary syndrome (ACS) who are determined to be at high risk due to an elevated concentration of natriuretic peptides. https://clinicaltrials.gov/ct2/show/NCT00409578

Link

https://clinicaltrials.gov/ct2/show/NCT00409578

Palabras clave

Versiones (1)
  1. 28/7/15 28/7/15 -
Subido en

28 de julio de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Aliskiren and Valsartan Acute Coronary Syndrome NCT00409578

Inglés

Eligibility Criteria

1 formularios  
  1. StudyEvent: ODM
    1. Eligibility Criteria
Inclusion Criteria
Descripción

Inclusion Criteria

Male or female outpatients
Descripción

Male or female outpatients

Tipo de datos

boolean

Alias
UMLS CUI-1
C0079399
18 years old or older
Descripción

18 years old or older

Tipo de datos

boolean

Alias
UMLS CUI-1
C0001779
Final diagnosis of acute coronary syndrome
Descripción

Final diagnosis of acute coronary syndrome

Tipo de datos

boolean

Alias
UMLS CUI-1
C0948089
ischemic chest discomfort
Descripción

ischemic chest discomfort

Tipo de datos

boolean

Alias
UMLS CUI-1
C0008031
Elevated concentrations of natriuretic peptide 3-10 days after admission for their qualifying acute coronary syndrome event
Descripción

Elevated concentrations of natriuretic peptide 3-10 days after admission for their qualifying acute coronary syndrome event

Tipo de datos

boolean

Alias
UMLS CUI-1
C1095989
Exclusion criteria
Descripción

Exclusion criteria

Presence of clinically overt heart failure
Descripción

Presence of clinically overt heart failure

Tipo de datos

boolean

Alias
UMLS CUI-1
C0018801
Known evidence of left ventricular systolic dysfunction
Descripción

Known evidence of left ventricular systolic dysfunction

Tipo de datos

boolean

Alias
UMLS CUI-1
C1277187
Percutaneous coronary intervention (PCI) less than 24 hours before randomization
Descripción

Percutaneous coronary intervention (PCI) less than 24 hours before randomization

Tipo de datos

boolean

Alias
UMLS CUI-1
C1532338
chronic ACEI therapy
Descripción

chronic ACEI therapy

Tipo de datos

boolean

Alias
UMLS CUI-1
C0003015
chronic ARB therapy
Descripción

chronic ARB therapy

Tipo de datos

boolean

Alias
UMLS CUI-1
C0521942
Volver a la parte superior de la página

Similar models

Eligibility Criteria

1 formularios
  1. StudyEvent: ODM
    1. Eligibility Criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion Criteria
Gender
Item
Male or female outpatients
boolean
C0079399 (UMLS CUI-1)
Age
Item
18 years old or older
boolean
C0001779 (UMLS CUI-1)
Acute coronary syndrome
Item
Final diagnosis of acute coronary syndrome
boolean
C0948089 (UMLS CUI-1)
Chest pain
Item
ischemic chest discomfort
boolean
C0008031 (UMLS CUI-1)
BNP
Item
Elevated concentrations of natriuretic peptide 3-10 days after admission for their qualifying acute coronary syndrome event
boolean
C1095989 (UMLS CUI-1)
Item Group
Exclusion criteria
Heart failure
Item
Presence of clinically overt heart failure
boolean
C0018801 (UMLS CUI-1)
Left ventricular systolic dysfunction
Item
Known evidence of left ventricular systolic dysfunction
boolean
C1277187 (UMLS CUI-1)
PCI
Item
Percutaneous coronary intervention (PCI) less than 24 hours before randomization
boolean
C1532338 (UMLS CUI-1)
ACE inhibitors
Item
chronic ACEI therapy
boolean
C0003015 (UMLS CUI-1)
ARB
Item
chronic ARB therapy
boolean
C0521942 (UMLS CUI-1)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial